• KOLs
  • Cord Blood
  • Minyoung Kim, M.d.

Direct Impact

Concepts for which MinYoung Kim M D has direct influence:

cord blood
cerebral palsy
developmental delay
allogeneic umbilical
brain injury
therapy children
neurodegenerative disorders

Prominent publications by MinYoung Kim, M.D.

KOL-Index: 2 This study aims to evaluate the efficacy of umbilical cord blood therapy for children with cerebral palsy. Detailed Description Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability.Many experimental animal studies have revealed that umbilical cord blood is useful to ...
Known for
Palsy Aims | Disorder Movement | Injury Brain | Evaluate Umbilical
KOL-Index: 2 This purpose of this phase 1 study is to investigate the safety and efficacy of erythropoetin for children with cerebral palsy. Detailed Description Cerebral palsy is a disorder of movement and posture resulted from a nonprogressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability.Many experimental animal studies have revealed that erythropoietin is ...
Known for
Neurological Injury | Nonprogressive Lesion | Immature Brain
KOL-Index: 2 This open-label study aims to analyze cytokines related to clinical outcomes of allogeneic umbilical cord blood therapy for children with cerebral palsy. Detailed Description Cerebral palsy (CP) is a group of neurodevelopmental conditions with abnormal movement and posture resulted from a non-progressive cerebral disturbance. It is the most common cause of motor disability in childhood. Most ...
Known for
Therapy Open | Palsy Detailed | Children Animal | Ucb Restorative
KOL-Index: 2 This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood (UCB) therapy for patients with stroke. Detailed Description Stroke is one of the most common etiologies causing disability in developed countries. There remains no proven treatments except tissue plasminogen activator currently. Based on promising results of cell therapy in animal ...
Known for
Detailed Stroke | Open Trial | Conducted Investigate | Proven Treatments
KOL-Index: 2 This open label trial is conducted to investigate the efficacy and safety of the combination therapy of allogeneic umbilical cord blood (UCB) and granulocyte-colony stimulating factor (G-CSF) for patients with brain injury or neurodegenerative disorders. Detailed Description Current treatments for brain injury or neurodegenerative disorders are palliative rather than curative. Preclinical ...
Known for
Csf Brain | Therapy Cord | Disorders Combination | Injury Neurodegenerative
KOL-Index: 2 This randomized controlled study aims to evaluate the efficacy of umbilical cord blood therapy for children with cerebral palsy. Detailed Description Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability.Many experimental animal studies have revealed that umbilical cord ...
Known for
Immature Brain | Neurological Injury
KOL-Index: 2 This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood (UCB) therapy for patients with acquired brain injury. Detailed Description Acquired brain injury (ABI) means brain damage caused by events after birth, rather than as part of a genetic or congenital disorders. Those with ABI suffer from cognitive, physical, or behavioral impairments ...
Known for
Injury Open | Investigate Safety | Traumatic Brain | Trial Conducted
KOL-Index: 2 This open-label study aims to evaluate the safety and efficacy of umbilical cord blood therapy for children with global developmental delay. Detailed Description Global developmental delay (GDD) is a subset of developmental disabilities defined as significant delay in two or more of the following developmental domains: gross/fine motor, speech/language, cognition, social/personal, and ...
Known for
Safety Umbilical | Aims Evaluate | Gdd Developmental | Delay Detailed
KOL-Index: 2 This open-label study aims to evaluate the safety and efficacy of autologous or allogeneic umbilical cord blood therapy for children with global developmental delay. Detailed Description Global developmental delay is defined as significant delay in two or more of the following developmental domains: gross/fine motor, speech/language, cognition, social/personal, and activities of daily ...
Known for
Aims Evaluate | Delay Detailed | Autologous Allogeneic | Inherited Metabolic

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172